Home › Major Depressive Disorder › Maryland › Germantown
Major Depressive Disorder clinical trials in Germantown, MD
5 studies for Major Depressive Disorder are looking for participants at sites in and around Germantown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Sunstone Medical, PC, Rockville · 9 mi away
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- Delricht Research - Rockville, Rockville · 9 mi away
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RecruitingPhase 2
- Draig Clinical Site, Gaithersburg · 4 mi away
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Gaithersburg · 4 mi away
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- Sunstone Medical, PC, Rockville · 9 mi away
Major Depressive Disorder trials in other cities
- New York City, NY36 studies
- Boston, MA31 studies
- Atlanta, GA25 studies
- Philadelphia, PA23 studies
- Orlando, FL19 studies
- Miami, FL18 studies
- Chicago, IL17 studies
- Tampa, FL17 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Germantown
- Non-Small Cell Lung Cancer17 studies
- Schizophrenia11 studies
- Breast Cancer10 studies
- Lung Cancer9 studies
- Cancer (all types)7 studies
- Depression7 studies
- Obesity7 studies
- Type 2 Diabetes7 studies
- Cardiovascular Disease6 studies
- Bladder Cancer6 studies
- Overweight5 studies
- High Blood Pressure4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.